CIRRUS HD-OCT
Device
Carl Zeiss Meditec, Inc.
Total Payments
$5.0M
Transactions
5,691
Doctors
3,319
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $649,286 | 801 | 509 |
| 2023 | $438,493 | 459 | 278 |
| 2022 | $258,151 | 430 | 306 |
| 2021 | $82,462 | 193 | 168 |
| 2020 | $928,152 | 300 | 214 |
| 2019 | $862,834 | 1,167 | 782 |
| 2018 | $990,578 | 966 | 661 |
| 2017 | $817,023 | 1,375 | 1,051 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.7M | 62 | 34.6% |
| Consulting Fee | $1.7M | 427 | 33.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $505,425 | 242 | 10.1% |
| Food and Beverage | $288,470 | 4,300 | 5.7% |
| Gift | $273,027 | 64 | 5.4% |
| Travel and Lodging | $263,124 | 409 | 5.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $214,445 | 127 | 4.3% |
| Long term medical supply or device loan | $67,686 | 52 | 1.3% |
| Education | $14,315 | 6 | 0.3% |
| Honoraria | $200.00 | 2 | 0.0% |
Payments by Type
General
$3.3M
5,629 transactions
Research
$1.7M
62 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Analysis of OCT data (DCA-OCT) for vasculature imaging in the eye | Carl Zeiss Meditec, Inc. | $633,391 | 0 |
| Investigating the clinical utility of using differential complex analysis of OCT data (DCA-OCT) for vasculature imaging in the eye | Carl Zeiss Meditec, Inc. | $237,368 | 0 |
| Investigating the clinical utility of OCT for Imaging in the Eye | Carl Zeiss Meditec, Inc. | $165,000 | 0 |
| Repeatability and Reproducibility of CIRRUS 6000 AND Avanti Macular Angiography Metrics on Diseased Eyes and comparison to CIRRUS 5000 HD OCT | Carl Zeiss Meditec, Inc. | $164,887 | 0 |
| Sensitivity and specificity of IOL Master 700 for detecting macular pathology as compared to Cirrus | Carl Zeiss Meditec, Inc. | $53,000 | 1 |
| Collection of OCT and OCT Angiography data from human eyes with a variety fo retinal and optic nerve diseases with CIRRUS HD-OCT with Zeiss AngioPlex. | Carl Zeiss Meditec, Inc. | $51,602 | 0 |
| Investigate deep learning for ophthalmic imaging and functional testing | Carl Zeiss Meditec, Inc. | $50,000 | 0 |
| Collection of OCT and OCT Angiography data from human eyes with a variety fo retinal and optic nerve diseases with CIRRUS HD-OCT with Zeiss AngioPlex | Carl Zeiss Meditec, Inc. | $26,754 | 0 |
| Evaluating the Retinal Microvasculature in Mild Cognitive Impairment and Alzheimer's Disease using Optical Coherence Tomography Angiography. | Carl Zeiss Meditec, Inc. | $25,652 | 0 |
| Cirrus HD-OCT External Confirmation Studies Protocol | Carl Zeiss Meditec, Inc. | $15,625 | 0 |
| CIRRUS HD OCT R and D Confirmation Studies Protocol | Carl Zeiss Meditec, Inc. | $14,756 | 0 |
| Use of the VisuMax Femtosecond Laser Lenticule Removal Procedure for the Correction of Myopia With or Without Astigmatism | Carl Zeiss Meditec, Inc. | $11,375 | 1 |
| Cirrus HD-OCT R and D Confirmation Studies | Carl Zeiss Meditec, Inc. | $8,775 | 0 |
| Use of CIRRUS HD-OCT to measure Epithelial Thickness in eyes that are pre and post Lasik surgery. | Carl Zeiss Meditec, Inc. | $8,459 | 0 |
| Clinical Utility fo OCT Angiography for Glaucoma | Carl Zeiss Meditec, Inc. | $4,109 | 0 |
| Comparison of Clinical Feature Identification Between PLEX Elite 9000 and CIRRUS HD-OCT Systems in Eyes with a Variety of Retinal Pathologies | Carl Zeiss Meditec, Inc. | $3,000 | 0 |
| Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk. | Carl Zeiss Meditec, Inc. | $1,869 | 0 |
| Peripheral DR Lesions on Ultrawide-Field Fundus Images and Risk of Diabetic Retinopathy Worsening over Time Study. | Carl Zeiss Meditec, Inc. | $1,869 | 0 |
| CLARUS 700 ICGA Comparison Study | Carl Zeiss Meditec, Inc. | $1,486 | 0 |
Top Doctors Receiving Payments for CIRRUS HD-OCT — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , O.D | Corneal and Contact Management | Louisville, KY | $12,576 | 16 |
| , OD, PHD | Optometrist | Glendale, AZ | $11,687 | 1 |
| , M.D | Ophthalmology | Houston, TX | $11,375 | 3 |
| Gregg Kokame | Ophthalmology | Aiea, HI | $11,213 | 5 |
| , O.D | Optometrist | Brooklyn, NY | $11,100 | 22 |
| , MD | Ophthalmology | Green Bay, WI | $10,878 | 1 |
| , MD | Specialist | Boston, MA | $10,383 | 13 |
| , M.D | Internal Medicine | Cleveland, OH | $10,352 | 8 |
| , MD | Ophthalmology | New York, NY | $10,087 | 7 |
| , O.D | Corneal and Contact Management | Missouri City, TX | $9,886 | 27 |
| , M.D | Retina Specialist | Miami, FL | $9,845 | 7 |
| , MD | Ophthalmology | Temple, TX | $9,784 | 3 |
| , M.D | Specialist | Houston, TX | $9,783 | 7 |
| , MD | Ophthalmology | Cleveland, OH | $9,637 | 3 |
| , O.D | Optometrist | Santa Clara, CA | $9,315 | 9 |
| , MD | Ophthalmology | Erie, PA | $9,246 | 7 |
| Sarah Read | Ophthalmology | Miami, FL | $9,237 | 3 |
| , MD | Ophthalmology | Cleveland, OH | $8,750 | 6 |
| , M.D., M.B.A | Ophthalmology | Miami, FL | $8,635 | 9 |
| , M.D | Ophthalmology | York, PA | $8,574 | 6 |
| Henry Tran | Optometrist | Fullerton, CA | $8,400 | 2 |
| , MD | Ophthalmology | La Jolla, CA | $8,268 | 8 |
| , MD | Ophthalmology | Portland, OR | $8,124 | 5 |
| , M.D | Ophthalmology | Brecksville, OH | $7,903 | 7 |
| , MD | Ophthalmology | Sacramento, CA | $7,895 | 3 |
Ad
Manufacturing Companies
- Carl Zeiss Meditec, Inc. $4.5M
- Carl Zeiss Meditec USA, Inc. $533,473
Product Information
- Type Device
- Total Payments $5.0M
- Total Doctors 3,319
- Transactions 5,691
About CIRRUS HD-OCT
CIRRUS HD-OCT is a device associated with $5.0M in payments to 3,319 healthcare providers, recorded across 5,691 transactions in the CMS Open Payments database. The primary manufacturer is Carl Zeiss Meditec, Inc..
Payment data is available from 2017 to 2024. In 2024, $649,286 was paid across 801 transactions to 509 doctors.
The most common payment nature for CIRRUS HD-OCT is "Unspecified" ($1.7M, 34.6% of total).
CIRRUS HD-OCT is associated with 19 research studies, including "Analysis of OCT data (DCA-OCT) for vasculature imaging in the eye" ($633,391).